• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性银屑病关节炎的特征:一项对比分析。

Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis.

作者信息

Philippoteaux Cécile, Marty-Ane Anne, Cailliau Emeline, Labreuche Julien, Philippe Peggy, Cortet Bernard, Paccou Julien, Flipo Rene-Marc, Letarouilly Jean-Guillaume

机构信息

Rheumatology Department, Lille University Hospital, Lille, France.

Rheumatology Department, Lille University Hospital, Lille, France.

出版信息

Semin Arthritis Rheum. 2023 Dec;63:152275. doi: 10.1016/j.semarthrit.2023.152275. Epub 2023 Oct 5.

DOI:10.1016/j.semarthrit.2023.152275
PMID:37852155
Abstract

OBJECTIVE

The EULAR task force recently published the difficult-to-treat rheumatoid arthritis (D2T RA) criteria, however, a definition of D2T patients in psoriatic arthritis (PsA) is still lacking. To date, we have little data concerning D2T PsA, especially in real-world. One of the limitations of the D2T RA EULAR definition is the absence of a temporal criterion. The primary endpoint of this work was to study the characteristics of D2T PsA patients using the EULAR definition. The second objective was to study a sub-group of patients with a predefined more stringent definition including a temporal criterion.

METHODS

A retrospective study was performed in a tertiary center. D2T PsA was defined as failure of ≥ 2 b/tsDMARDs with different mechanism of action. Very D2T PsA was defined as failure of ≥ 2 b/tsDMARDs in less than 2 years of follow-up. D2T and Very D2T PsA patients were compared to nD2T PsA patients using statistical tests.

RESULTS

150 PsA patients were included (from 2004 to 2015): 49 D2T PsA and 101 nD2T PsA. D2T PsA was associated with a higher prevalence of axial involvement (p=0.030), axial and/or peripheral structural damage (p=0.007) at baseline and more bDMARDs discontinuation due to poor dermatological control (p=0.005). There was no significant difference regarding comorbidities such as obesity, smoking status, fibromyalgia or depression. In multivariate analysis, peripheral structural damage at baseline was found to be a predictive factor for D2T PsA with an OR of 2.57 (1.16 to 5.69; p=0.020). 17 PsA (11.3%) patients were categorized as Very D2T PsA. When compared to nD2T group, proportion of obesity was higher (p=0.015) and axial involvement was more prevalent in the Very D2T group (p=0.020).

CONCLUSION

D2T PsA patients had a higher prevalence of axial involvement, peripheral structural damage and therapeutic discontinuation due to poor dermatological control whereas Very D2T PsA patients were more likely obese with axial involvement. Very D2T PsA represent a minim proportion among patients when applying a more stringent definition. Pending the PsA D2T definition by the European and American societies, this study highlights some characteristics that may help practitioners better identify D2T patients.

摘要

目的

欧洲抗风湿病联盟(EULAR)特别工作组最近发布了难治性类风湿关节炎(D2T RA)标准,然而,银屑病关节炎(PsA)中D2T患者的定义仍缺失。迄今为止,我们关于D2T PsA的数据很少,尤其是在真实世界中。D2T RA的EULAR定义的局限性之一是缺乏时间标准。这项研究的主要终点是使用EULAR定义研究D2T PsA患者的特征。第二个目标是研究一组具有预先定义的更严格定义(包括时间标准)的患者亚组。

方法

在一家三级中心进行了一项回顾性研究。D2T PsA被定义为≥2种具有不同作用机制的生物/靶向合成改善病情抗风湿药(b/tsDMARDs)治疗失败。极难治性PsA(Very D2T PsA)被定义为在不到2年的随访中≥2种b/tsDMARDs治疗失败。使用统计检验将D2T和Very D2T PsA患者与非难治性PsA(nD2T PsA)患者进行比较。

结果

纳入了150例PsA患者(2004年至2015年):49例D2T PsA和101例nD2T PsA。D2T PsA与基线时更高的轴向受累患病率(p = 0.030)、轴向和/或外周结构损伤患病率(p = 0.007)以及更多因皮肤控制不佳导致的生物制剂停药相关(p = 0.005)。在肥胖、吸烟状况、纤维肌痛或抑郁症等合并症方面没有显著差异。在多变量分析中,发现基线时的外周结构损伤是D2T PsA的预测因素,比值比为2.57(1.16至5.69;p = 0.020)。17例PsA(11.3%)患者被归类为Very D2T PsA。与nD2T组相比,肥胖比例更高(p = 0.015),Very D2T组中轴向受累更普遍(p = 0.020)。

结论

D2T PsA患者轴向受累、外周结构损伤以及因皮肤控制不佳导致治疗停药的患病率更高,而Very D2T PsA患者更可能肥胖且有轴向受累。在应用更严格定义时,Very D2T PsA在患者中占比极小。在欧美社会给出PsA的D2T定义之前,本研究突出了一些可能有助于医生更好识别D2T患者的特征。

相似文献

1
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis.难治性银屑病关节炎的特征:一项对比分析。
Semin Arthritis Rheum. 2023 Dec;63:152275. doi: 10.1016/j.semarthrit.2023.152275. Epub 2023 Oct 5.
2
Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study.难治性中轴型脊柱关节炎的特征:一项真实世界多中心研究的结果。
Joint Bone Spine. 2024 Mar;91(2):105670. doi: 10.1016/j.jbspin.2023.105670. Epub 2023 Nov 29.
3
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study.难以治疗的类风湿关节炎患者的特征:一项描述性回顾性队列研究。
Adv Rheumatol. 2024 Aug 6;64(1):55. doi: 10.1186/s42358-024-00396-6.
4
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients.时间揭示的真相和 D2T-RA 的大理石般定义:对难治性 RA 患者中难治状态持续存在的回顾性分析。
Arthritis Res Ther. 2024 Sep 17;26(1):161. doi: 10.1186/s13075-024-03390-x.
5
[Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results].[实际临床实践中难治性类风湿关节炎。初步结果]
Ter Arkh. 2022 Jun 17;94(5):661-666. doi: 10.26442/00403660.2022.05.201489.
6
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.识别和评估潜在难治性银屑病关节炎患者的特征:希腊银屑病关节炎注册研究的探索性分析。
Rheumatology (Oxford). 2024 Sep 1;63(9):2427-2432. doi: 10.1093/rheumatology/keae263.
7
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort.银屑病关节炎潜在“难治性”患者的临床特征:一项纵向队列的回顾性分析
Rheumatol Ther. 2022 Aug;9(4):1193-1201. doi: 10.1007/s40744-022-00461-w. Epub 2022 May 25.
8
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease.难治性类风湿关节炎:相关因素及疾病负担。
Rheumatology (Oxford). 2021 Aug 2;60(8):3778-3788. doi: 10.1093/rheumatology/keaa860.
9
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.揭示难治性类风湿关节炎:来自 KOBIO 登记处的生物制剂或靶向合成 DMARDs 的长期影响。
Arthritis Res Ther. 2023 Sep 19;25(1):174. doi: 10.1186/s13075-023-03165-w.
10
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management.《难治性类风湿关节炎的研究进展:定义、临床表现和治疗》
Curr Rheumatol Rep. 2023 Dec;25(12):285-294. doi: 10.1007/s11926-023-01117-6.

引用本文的文献

1
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study.在皮肤科-风湿病联合门诊随访的以难治性银屑病关节炎患者为主的人群中,比美吉珠单抗的真实世界有效性:一项为期24周的多中心研究
Rheumatol Ther. 2025 Jul 28. doi: 10.1007/s40744-025-00784-4.
2
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients.银屑病关节炎合并代谢综合征的患者表现出一种难以治疗的表型:这是仍未明确的患者亚组定义中的又一块拼图。
RMD Open. 2025 Jun 22;11(2):e005717. doi: 10.1136/rmdopen-2025-005717.
3
Burden and determinants of multi-b/tsDMARD failure in psoriatic arthritis.
银屑病关节炎中多种生物制剂/靶向合成改善病情抗风湿药治疗失败的负担及决定因素
Arthritis Res Ther. 2025 Mar 4;27(1):46. doi: 10.1186/s13075-025-03518-7.
4
Exploring the Cutting Edge: A Recap of EULAR & ACR 2023 Highlights for Spondyloarthritis, including Psoriatic Arthritis.探索前沿:2023年欧洲抗风湿病联盟(EULAR)和美国风湿病学会(ACR)脊柱关节炎(包括银屑病关节炎)亮点回顾
Mediterr J Rheumatol. 2024 Dec 31;35(Suppl 3):534-541. doi: 10.31138/mjr.040524.aeh. eCollection 2024 Dec.
5
Difficult to Treat Psoriatic Arthritis: The Road So Far.难以治疗的银屑病关节炎:迄今之路
Mediterr J Rheumatol. 2024 Dec 31;35(Suppl 3):513-518. doi: 10.31138/mjr.2506241.dtt. eCollection 2024 Dec.
6
Refractory psoriatic arthritis: emerging concepts in whole process management.难治性银屑病关节炎:全程管理中的新观念
Clin Rheumatol. 2025 Feb;44(2):583-590. doi: 10.1007/s10067-024-07267-x. Epub 2025 Jan 14.
7
Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort.难治性银屑病关节炎:在真实队列中使用统计模型完善定义
Front Med (Lausanne). 2024 Dec 16;11:1509082. doi: 10.3389/fmed.2024.1509082. eCollection 2024.
8
A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.类风湿关节炎、银屑病关节炎和轴性脊柱关节炎共病及其危险因素患病率的比较,重点关注心血管疾病:来自单一中心真实世界队列的数据
Rheumatol Int. 2024 Dec;44(12):2817-2828. doi: 10.1007/s00296-024-05740-z. Epub 2024 Nov 11.
9
Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals.解读难治性银屑病关节炎(D2T-PsA):来自医疗保健专业人员国际调查的GRAPPA观点
Rheumatol Adv Pract. 2024 Jun 19;8(3):rkae074. doi: 10.1093/rap/rkae074. eCollection 2024.
10
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.识别和评估潜在难治性银屑病关节炎患者的特征:希腊银屑病关节炎注册研究的探索性分析。
Rheumatology (Oxford). 2024 Sep 1;63(9):2427-2432. doi: 10.1093/rheumatology/keae263.